StockStory flags Veralto, Toll Brothers, and Labcorp as mid-cap stocks to avoid

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory highlights three mid-cap stocks it recommends investors avoid: Veralto, Toll Brothers, and Labcorp. Veralto, a water analytics firm spun off from Danaher, posted annual revenue growth of just 4.4% over four years and faces shaky demand with projected sales growth of 6.5%. Toll Brothers, the luxury homebuilder, saw its backlog decline by an average of 9.1% over two years and expects a 2.9% sales drop, while earnings per share contracted 5.7% annually. Labcorp, the laboratory services giant, experienced a 1.6% annual sales decline over five years and an 11.1% annual drop in earnings per share, with organic revenue underperforming.

Impact on stocks 4

Biotech & Genomic Medicine▼ · 2 stocks
Consumer Discretionary▼ · 1 stocks
Toll Brothers Inc
TOL
▼ NegativeDemandrelevance

Toll Brothers saw its backlog decline by an average of 9.1% over two years and expects a 2.9% sales drop

Climate Adaptation & Water▼ · 1 stocks
Veralto Corporation
VLTO
▼ NegativeDemandrelevance

Veralto posted annual revenue growth of just 4.4% over four years and faces shaky demand with projected sales growth of 6.5%

© 2026 MarketDXNews